Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 272503
                    [Title] => Chemoprevention of esophageal and gastric cancers
                    [Summary] => Gastroesophageal cancers include cancer of the stomach, gastroesophageal junction, and esophagus, which differ markedly in their molecular and biologic characteristics and epidemiologic profiles. Gastric cancer is the second leading cause of cancer-related deaths worldwide and has been associated with environmental factors including diets high in fatty, pickled, smoked, or salty foods; diets low in fresh fruits and vegetables; and gastric mucosal infection with Helicobacter pylori. Recently, a study evaluated the potential benefits of antioxidant supplements and/or H.
                    [DatePublished] => 2005-04-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

ALTHOUGH BARRETT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 272503
                    [Title] => Chemoprevention of esophageal and gastric cancers
                    [Summary] => Gastroesophageal cancers include cancer of the stomach, gastroesophageal junction, and esophagus, which differ markedly in their molecular and biologic characteristics and epidemiologic profiles. Gastric cancer is the second leading cause of cancer-related deaths worldwide and has been associated with environmental factors including diets high in fatty, pickled, smoked, or salty foods; diets low in fresh fruits and vegetables; and gastric mucosal infection with Helicobacter pylori. Recently, a study evaluated the potential benefits of antioxidant supplements and/or H.
                    [DatePublished] => 2005-04-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Chemoprevention of esophageal and gastric cancers

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | April 3, 2005 - 12:00am

Gastroesophageal cancers include cancer of the stomach, gastroesophageal junction, and esophagus, which differ markedly in their molecular and biologic characteristics and epidemiologic profiles. Gastric cancer is...

Opinion